MUSTANG BIO, INC. Professional Fees
MUSTANG BIO, INC. (MBIO) reported Professional Fees of $120.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ProfessionalFees · last filed 2018-03-29
- MUSTANG BIO, INC. professional fees for the quarter ending 2017-12-31 was $30.00K, a 66.56% decline year-over-year.
- MUSTANG BIO, INC. professional fees for the quarter ending 2017-09-30 was $60.00K, a 242.86% increase year-over-year.
- MUSTANG BIO, INC. professional fees for the quarter ending 2017-06-30 was $22.50K, a 87.50% increase year-over-year.
- MUSTANG BIO, INC. professional fees for the quarter ending 2017-03-31 was $22.50K, a 2268.42% increase year-over-year.
- MUSTANG BIO, INC. professional fees for fiscal 2017 was $120.00K, a 0.00% change from fiscal 2016.
- MUSTANG BIO, INC. professional fees for fiscal 2016 was $120.00K.
| Period end | Professional Fees 3 month | Professional Fees 6 month | Professional Fees 9 month | Professional Fees 12 month |
|---|---|---|---|---|
| 2017-12-31 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $90.00K derived: sum of 2 quarters · filed 2018-03-29 | $112.50K derived: sum of 3 quarters · filed 2018-03-29 | $120.00K 10-K · filed 2018-03-29 |
| 2017-09-30 | $60.00K 10-Q · filed 2017-11-14 | $82.50K derived: sum of 2 quarters · filed 2017-11-14 | $90.00K 10-Q · filed 2017-11-14 | $194.70K derived: sum of 4 quarters · filed 2018-03-29 |
| 2017-06-30 | $22.50K 10-Q · filed 2017-08-14 | $45.00K 10-Q · filed 2017-08-14 | $134.70K derived: sum of 3 quarters · filed 2018-03-29 | $152.20K derived: sum of 4 quarters · filed 2018-03-29 |
| 2017-03-31 | $22.50K 10-Q · filed 2017-05-15 | $112.20K derived: sum of 2 quarters · filed 2018-03-29 | $129.70K derived: sum of 3 quarters · filed 2018-03-29 | $141.70K derived: sum of 4 quarters · filed 2018-03-29 |
| 2016-12-31 | $89.70K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $107.20K derived: sum of 2 quarters · filed 2018-03-29 | $119.20K derived: sum of 3 quarters · filed 2018-03-29 | $120.00K 10-K · filed 2018-03-29 |
| 2016-09-30 | $17.50K 10-Q · filed 2017-11-14 | $29.50K derived: sum of 2 quarters · filed 2017-11-14 | $30.30K 10-Q · filed 2017-11-14 | |
| 2016-06-30 | $12.00K 10-Q · filed 2017-08-14 | $13.00K 10-Q · filed 2017-08-14 | ||
| 2016-03-31 | $950.00 10-Q · filed 2017-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |